Mats Danielsson has developed X-ray technology which has improved mammography and he is now working on next generation computer tomography. He is a Professor of medical imaging at the Royal Institute of Technology and Scientific Director at MedTechLabs.
“Our goal is for MTL to become a world-leading medical technology research center, where we will develop treatments that will benefit large patient groups. We are results-oriented and will really make a difference, “says Mats Danielsson.
Over the last 30 years, there has been a strong development of medical technology that has affected survival and quality of life in many people’s diseases, he states.
“Ten years ago, the chest was sawn and cut up in cardiac surgery, today, the same operations can be done with minimal invasive technology that allows you to enter into small instruments. It saves human life. In the case of stroke, there has been a fantastic development that we are only at the beginning of.
Mats Danielsson’s research team at KTH is currently working on developing next-generation computerized tomography, a layer X-ray that will be able to produce X-ray pictures where it is possible to detect very small cancer tumors. It also becomes easier to see how the tumor develops and if it is responsive to treatment. The technology will be tested on MedTechLabs.
Mats Danielsson has been employed at KTH since 1999. He has studied at the CERN laboratory in Switzerland, a world leading center in particle physics and high energy physics, and at the Berkley Laboratory in the United States.
Together with his colleagues, Mats Danielsson has developed the X-ray technology Microdose Mammography, which provides high image quality with low radiation dose. The technique has meant that more cases of breast cancer are detected early. It is used in many clinics in Sweden and around the world.
Staffan Holmin has developed a new method of delivering cells and substances to hard-to-reach organs. He is a professor at the Department of Clinical Neuroscience at Karolinska Institutet, senior physician and R & D manager at neuroradiology, at the Karolinska University Hospital and Scientific director at MedTechLabs. “We in the healthcare sector see the needs and can create a wish list to discuss with the engineers. By combining our knowledge, we can solve problems that cannot be solved, “says Staffan Holmin, within MedTechLab’s solution.
Staffan Holmin leads a research group at Karolinska Institutet, focusing on endovascular engineering and medical imaging. An example of endovascular technique is a new method of delivering cells or substances through the vessel wall to hard-to-reach organs without causing unwanted side effects.
“The method can be of great importance to patients with myocardial infarction, kidney disease and cancer in different organs,” says Staffan Holmin.
Other examples are further development of imaging diagnosis in acute stroke and thrombectomy, which involves diagnosing and removing blood clots in the brain using a narrow catheter inserted through the groin. The method allows more patients with stroke to survive and recover.
Staffan Holmin is both a researcher and a doctor. He works clinically at the Karolinska University Hospital, where he operates patients, including those who have stroke caused by blood clots or bleeding. He is also part of the KTH group who is developing next generation computerized tomography.
He studied at KI in 1997 and has been a doctor at Karolinska University Hospital since 1999. He has also studied at Hospital Bicêtre, Paris.